Magnesium supplementation in pregnancy

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Makrides, Maria ^a,b   Crosby, Danielle D ^b,c   Bain, Emily ^b   Crowther, Caroline A ^b,d  

^a SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c LYELL MCEWIN HOSPITAL   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; MAGNESIUM ASPARTATE; MAGNESIUM CITRATE; MAGNESIUM DERIVATIVE; MAGNESIUM GLUCONATE; MAGNESIUM OXIDE; MAGNESIUM STEARATE; UNCLASSIFIED DRUG;

ANTEPARTUM HEMORRHAGE; APGAR SCORE; BIRTH WEIGHT; BREECH PRESENTATION; CONGENITAL MALFORMATION; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE SEVERITY; ECLAMPSIA; FETUS HEART RATE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MECONIUM ASPIRATION; NEWBORN DEATH; OUTCOME ASSESSMENT; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; CONGENITAL DISORDER; EPIDEMIOLOGY; FEMALE; INFANT MORTALITY; META ANALYSIS; MORTALITY; NEWBORN; ORAL DRUG ADMINISTRATION; PRE-ECLAMPSIA; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADMINISTRATION, ORAL; CONGENITAL ABNORMALITIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MAGNESIUM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STILLBIRTH;

EID: 84928255244     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000937.pub2     Document Type: Review

References (46)

1. D'Almeida A, Carter JP, Antol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and placebo in preventing pre-eclampsia. Women and Health 1992;19:117-31.
2. Arikan G, Gucer F, Scholl W, Weiss PAM. Preterm labour during oral magnesium supplementation in uncomplicated pregnancies [Fruhgeburtlichkeit unter oraler magnesium substitution bei unkomplizierten schwangerschaften: eine randomisiert kontrolliert klinische studie]. Geburtshilfe und Frauenheilkunde 1997;57:491-5.
3. Arikan G, Panzitt T, Gaucer F, Boritsch J, Trojovski A, Haeusler MCH. Oral magnesium supplementation and the prevention of preterm labor. American Journal of Obstetrics and Gynaecology 1997;176:(1Pt2):S45.
4. Li S, Tian H. Oral low-dose magnesium gluconate preventing pregnancy induced hypertension (translation). Chunh-Hua-Fu-Chan-Ko-Tsa-Chih [Chinese Journal of Obstetrics and Gynaecology] 1997;32:613-5.
5. Balazs M, Kuti V, Morvay F, Varenka Zs, Szekely A, Szucs M. New data on the relationship between magnesium intake and the quality of pregnancy [Données nouvelles sur les relations entre l'apport alimentaire en magnésium et la qualité de la grossesse]. Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme 1980;21(6):525-7.
6. Balazs M, Morvai F, Szekely Z, Miklos Szucs, Varenka Z, Kuti V. Miscarriage and magnesium intake [Avortment spontané et apport en magnésium de la ration alimentaire]. Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme 1979;20(6):525-9.
7. Kovacs L, Molnar BG, Huhn E, Bodis L. Magnesium substitution in pregnancy. A prospective, randomized double-blind study [Magnesium substitution in der Schwangerschaft: eine prospektive, randomisierte doppelblindstudie]. Geburtshilfe und Frauenheilkunde 1988;48:595-600.
8. Kovacs L, Molnar GB, Huhn E, Bodis L. Magnesium substitution during pregnancy. A prospective randomised, double blind, clinical trial. Magyar Noorvosok Lapja 1988;51:9-14.
9. Zarcone R, Cardone G, Bellini P. Role of magnesium in pregnancy. Panminerva Medica 1994;36:168-70.
10. Sibai BM, Villar MA, Bary E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. American Journal of Obstetrics and Gynaecology 1989;161:115-9.
11. Martin RW, McColgin SW, Perry KG, McCaul JF, Hess LW, Martin JN, et al.Oral magnesium and the prevention of preterm labor in a high-risk group of patients. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians, Houston, Texas, USA. 1990:181.
12. Martin RW, Perry KG, Hess LW, Martin JN, Morrison JC. Oral magnesium and the prevention of preterm labor in a high-risk group of patients. American Journal of Obstetrics and Gynaecology 1992;166:144-7.
13. Fawcus S, Harrison V, Jordaan E. The prevention of neonatal encephalopathy: could magnesium supplementation during pregnancy play a role? [abstract]. 31st British International Congress of Obstetrics and Gynaecology. London, UK, 2007 July 4-6:102.
14. Harrison V, Fawcus S, Jordaan E. Magnesium supplementation and perinatal hypoxia: outcome of a parallel group randomised trial in pregnancy. British Journal of Obstetrics and Gynaecology 2007;114:994-1002.
15. Jaspers V, Spatling L, Fallenstein F, Quakernack K. Magnesium, calcium, haemoglobin, haematocrit, oestriol and HPL following magnesium substitution [supplementation] during pregnancy [Magnesium, kalzium, hamoglobin, hamatokrit, ostriol und HPL unter magnesium substitution in der schwangerschaft]. Geburtshilfe und Frauenheilkunde 1990;50:628-33.
16. Spatling L. Magnesium supplementation in pregnancy in pregnancy: a double-blind study. Proceedings of International Symposium on Advances in the Prevention of Low Birthweight, Cape Cod, Massachusetts, USA. 1988:197-201.
17. Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study. British Journal of Obstetrics and Gynaecology 1988;95:120-5.
18. Vetter K, Spaetling L. Magnesium substitution in pregnancy a double-blind study [Magnesium substitution in der schwangerschaft eine doppelblindstudie]. Archives of Gynaecology 1986;239:176-7.
19. Rudnicki M, Junge J, Frolich A, Ornvold K, Fischer-Rasmussen W. Magnesium supplement in pregnancy-induced hypertension A clinicopathological study. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1990;98:1123-7.
20. Rudnicki M, Frølich A, Fischer-Rasmussen W. Magnesium supplement in pregnancy-induced hypertension: effects on maternal and neonatal magnesium and calcium homeostasis. Mineral and Electrolyte Metabolism 1991;17(6):399-403.
21. Hallak M, Martinez-Poyer J, Brish L, Poole-Bryant K, Mammen EF, Sorokin Y. Magnesium sulfate impairs platelet function in normal pregnant women. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S142.
22. Hallak M, Martinez-Poyer J, Kruger M, Hassan S, Blackwell S, Sorokin Y. The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial. American Journal of Obstetrics and Gynecology 1999;181(5):1122-7.
23. Hallak M, Martinez-Poyer J, Kruger ML, Hassan S, Blackwell SC, Sorokin Y. Magnesium sulfate effect on fetal heart rate (FHR) parameters: A randomized, placebo controlled trial. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S155.
24. Hallak M, Martinez-Poyer J, Kruger ML, King M, Russell E, Sorokin Y. Magnesium sulfate transiently increases fetal breathing movements but not body movements. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S155.
25. Martinez-Poyer J, Hallak M, King M, Kruger M, Sorokin Y. Magnesium sulfate increases impedance to flow in the fetal systemic circulation but has no effect on the cerebral circulation. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S114.
26. Martinez-Poyer J, Hallak M, Russell E, Poole-Bryant K, Sorokin Y. Magnesium sulfate prolongs ventricular repolarisation in normal gravidas: A randomised, double-blind, placebo controlled study. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S142.
27. Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D. Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at 34 weeks gestational age. Journal of Obstetrics and Gynaecology Research 2012;38(5):763-71.
28. ISRCTN03989660. A randomized, double-blinded, placebo-controlled trial of oral magnesium for relief in pregnancy-induced leg cramps. http://www.controlled-trials.com/ISRCTN03989660/ (accessed 7 February 2013).
29. NCT01709968. Magnesium oxide monohydrate for nocturnal leg cramps (mgnlc); a prospective, randomized, double blind, placebo controlled clinical trial. http://clinicaltrials.gov/ct2/show/NCT01709968 (accessed 7 February 2013).
30. Nygaard IH, Valbø A, Pethick SV, Bøhmer T. Does oral magnesium substitution relieve pregnancy-induced leg cramps?. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2008;141(1):23-6.
31. Hammar M, Berg G, Solheim F, Larsson L. Calcium and magnesium status in pregnant women. A comparison between treatment with calcium and vitamin C in pregnant women with leg cramps. International Journal of Vitamin and Nutrition Research 1987;57:179-83.
32. Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L. The effect of oral magnesium substitution on pregnancy-induced leg cramps. American Journal of Obstetrics and Gynecology 1995;173(1):175-80.
33. ISRCTN98365455. Magnesium intervention during pregnancy. http://www.controlled-trials.com/isrctn/pf/98365455 (accessed 25 August 2011).
34. NCT01510665. Magnesium supplementation in the second trimester of pregnancy to overweight and obese individuals. http://clinicaltrials.gov/ct2/show/NCT01510665 (accessed 7 February 2013).
35. Arikan GM, Panzitt T, Gücer F, Scholz HS, Reinisch S, Haas J, et al.Course of maternal serum magnesium levels in low-risk gestations and in preterm labor and delivery. Fetal Diagnosis and Therapy 1999;14(6):332-6.
36. Conradt A, Weidinger H, Algayer. On the role of magnesium in fetal hypotrophy, pregnancy induced hypertension and pre-eclampsia. Magnesium Bulletin 1984;6:68-76.
37. Doyle W, Crawford MA, Wynn AH, Wynn SW. Maternal magnesium intake and pregnancy outcome. Magnesium Research 1989;2:205-10.
38. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI:].
39. Garrison SR, Allan GM, Sekhon RK, Musini VM, Khan KM. Magnesium for skeletal muscle cramps. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI:].
40. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
41. Subcommittee on Nutritional Status and Weight Gain During Pregnancy, Subcommittee on Dietary Intake and Nutrient Supplements During Pregnancy, Committee on Nutritional Status During Pregnancy and Lactation, Food, Nutrition Board. Institute of Medicine, National Academy of Sciences. Nutrition During Pregnancy. Washington DC: National Academy Press, 1990.
42. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
43. US Department of Health and Human Services: US FDA. Overview of dietary supplements: What is a dietary supplement?. http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110417.htm#what 2009 [accessed 25 Aug 2011].
44. Keirse MJNC. Routine magnesium supplementation in pregnancy. Pregnancy and Childbirth Module, The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Oxford, 1995 [revised 16 June 1993], issue 2.
45. Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI:].
46. Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI:].